Arnd Brandenburg

Performance of Novel Kidney Biomarkers in Preclinical Toxicity Studies

Dana Hoffmann, Melanie Adler, Vishal S. Vaidya et al. · Toxicological Sciences · 2010 · 113 citations

The enhanced value of combining conventional and “omics” analyses in early assessment of drug-induced hepatobiliary injury

Heidrun Ellinger‐Ziegelbauer, Melanie Adler, Alexander Amberg et al. · Toxicology and Applied Pharmacology · 2010 · 58 citations

Hepatology, Preclinical Drug Evaluation, Medicine +10

Successful treatment with ganciclovir of presumed Epstein-Barr meningo-encephalitis following bone marrow transplant.

P. L. I. Dellemijn, Arnd Brandenburg, Hubert G.M. Niesters et al. · PubMed · 1995 · 55 citations

Cross-study and cross-omics comparisons of three nephrotoxic compounds reveal mechanistic insights and new candidate biomarkers

Katja Matheis, Emmanuelle Com, Jean‐Charles Gautier et al. · Toxicology and Applied Pharmacology · 2010 · 40 citations

Biomarker (Medicine), Renal Function, Cross-omics Comparisons +12

New Peak Detection Performance Metrics from the MAM Consortium Interlaboratory Study

Trina Mouchahoir, John E. Schiel, Rich Rogers et al. · Journal of the American Society for Mass Spectrometry · 2021 · 39 citations · Full text